新闻资讯

Welcome to the 4WE62 booth of Qijian Biopharmaceutical at CPhI Shanghai, China

From June 19 to 21, 2024, Qijian Bio-Pharma will participate in CPhI Shanghai, China. Address: Shanghai New Expo Center, Booth No. 4WE62, welcome colleagues from all over the world come to discuss cooperation!  
19 2024/06

Welcome leaders of Jilin Provincial Department of Commerce to Qijian Bio-Pharmaceutical for investigation

In March 2024, the leaders of the High-Tech Products I&E Department of Jilin Provincial Department of Commerce visit Qijijan Bio-Pharmaceutical for investigation.
02 2024/04

In 2024,Jilin Qijian Bio-Pharmaceutical Co., Ltd will take part in the following worldwide professional exhibitions, welcome to visit us

1.  2024.5.7- 2024.5.9, CPHI North America to be held in Philadelphia USA, Address: Pennsylvania Covention Center Philadelphia,  Booth number: 1602   2.  2024.6.4-2024.6.6 FCE Pharma to be held in Sao Paulo Brazil, Address: Sao Paulo Expo, Booth number: CH76
19 2024/03

API (Butylphthalein) R&D Site, Production Site Verification and GMP Compliance Inspection of Jilin Qijian Bio-Pharmaceutical Co.,Ltd successfully passed.

API (Butylphthalein) R&D Site, Production Site Verification and GMP Compliance Inspection of Jilin Qijian Bio-Pharmaceutical Co.,Ltd successfully passed.
26 2023/09

CPHI Worldwide will be held in Barcelona, Spain on October 24-26, 2023.Jilin Qijian Bio-Pharmaceutical Co.,Ltd will attend the exhibition, Booth No: 80Q19, welcome to visit us.

CPHI Worldwide will be held in Barcelona, Spain on October 24-26, 2023.Jilin Qijian Bio-Pharmaceutical Co.,Ltd will attend the exhibition, Booth No: 80Q19, welcome to visit us.
26 2023/09

Great News! Qijian has obtained the human growth hormone (HGH) API export license signed and approved by the Food and Drug Administration。

In early 2022, Jilin Provincial Food and Drug Administration announced our "Drug export license for anabolic agents and peptide hormones" on website, it means that Qijian has become an approved enterprise for export human growth hormone (HGH) API in Jilin Province. Moreover in April 2021 Qijian obtained the "Drug Production License" for product HGH which updated and issued by CFDA, and the quality of HGH products meet the US FDA and EU GMP standards. In the new year, we will continue to improve our management level and provide customers with better products. 注: 出口准许证获批公示连接地址 吉林省药品监督管理局核(换)发《药品生产许可证》公告(2022年第1期)公示连接地址 药品生产许可查询地址  
24 2022/01
Previous page
1
2
3
4
5
6
7

Contact Us

Contact us

Username used for comment:
客户留言
Description:
WeChat

WeChat

Contact Us

Contact Us

ADD: No.707 Chaofan street, High-Tech Industrial Development Zone, Changchun City, Jilin province, China
Service Hotline:
0086-431-86561075
Fax:0086-431-88794098
Email:
export@qijianbio.com

Copyright:Jilin Qijian Bio-pharmaceutical Co., Ltd.  by:300.cn  吉ICP备20003293号  SEO

搜索
Search